Point72 Asset Management’s Tango Therapeutics TNGX Stock Holding History
Bought
Maintained
Sold
Other funds holding TNGX
SL
Point72 Asset Management's TNGX Position: Q3 2026 in Review
Point72 Asset Management sold out of Tango Therapeutics (TNGX) in Q3 2026, closing a stake of 298,339 shares — an estimated $9.33M sold.
Point72 Asset Management first reported a position in TNGX in Q1 2023 and held it in 6 quarters. The position peaked at $24.5M in Q3 2025. 255 funds tracked by Wall St. Rank hold TNGX as of Q3 2026.
- Point72 Asset Management reported no remaining Tango Therapeutics position as of Q3 2026 after selling out during the quarter.
- Point72 Asset Management sold 298,339 Tango Therapeutics shares in Q3 2026, an estimated $9.33M.
- Point72 Asset Management first reported a position in Tango Therapeutics in Q1 2023 and held it in 6 quarters.
- Point72 Asset Management's Tango Therapeutics position peaked at $24.5M in Q3 2025.
- 255 funds tracked by Wall St. Rank held Tango Therapeutics as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.